Mapping the conformational space accessible to catechol-O-methyltransferase.

Area of Science:

• Biochemistry and Structural Biology
• Neuroscience
• Pharmacology

Background:

• Catechol-O-methyltransferase (COMT) is crucial for deactivating catechol neurotransmitters in the prefrontal cortex.
• Imbalances in these neurotransmitters are linked to neurological conditions like schizophrenia, depression, and Parkinson's disease.
• COMT inhibition is a potential therapeutic strategy to restore neurotransmitter levels.

Purpose of the Study:

• To characterize the conformational landscape of COMT through various structural states.
• To provide insights into the enzyme's flexibility and its implications for drug design.
• To explore novel avenues for COMT inhibition beyond the closed enzyme conformation.

Main Methods:

• Determination of apo, semi-holo, holo, and Michaelis form crystal structures of COMT.
• Analysis of domain movements and loop conformations around the active site.
• Crystallographic studies of COMT in complex with inhibitors targeting the apo state.

Main Results:

• Revealed significant conformational flexibility in COMT, including domain swaps and loop movements.
• Identified substantial energetic costs associated with achieving the closed, catalytically active conformation.
• Presented crystallographic data supporting the inhibition of the apo state of COMT.

Conclusions:

• The dynamic nature of COMT makes it a challenging drug target, but also presents multiple opportunities for inhibition.
• Exploring non-closed conformations and the apo state offers promising alternative strategies for COMT inhibitor development.
• The presented structural data can guide the design of novel classes of COMT inhibitors for neurological disorders.